DOCPLANET COM INC
SC 13D/A, 2000-03-29
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DOCPLANET COM INC, 4, 2000-03-29
Next: JMB INCOME PROPERTIES LTD VII, 10-K405, 2000-03-29





                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON,  D.C.  20549

                                  SCHEDULE  13D/A

                 UNDER  THE  SECURITIES  EXCHANGE  ACT  OF  1934*
                                (AMENDMENT NO. 6)

                               DOCPLANET.COM,  INC.
                                (NAME  OF  ISSUER)

                           COMMON STOCK, NO PAR VALUE
                      (TITLE  OF  CLASS  OF  SECURITIES)


                                     256095100
                                  (CUSIP  NUMBER)

               CHARLES  R.  DRUMMOND                         Copies  to
               3000  W.  WARNER  AVENUE                      ----------
         SANTA  ANA,  CALIFORNIA  92704-5311           THOMPSON  KNIGHT  BROWN
                  PARKER  &  LEAHY  L.L.P.           1200  SMITH,  SUITE  3600
                  (714)  754-5800                        HOUSTON,  TX  77002
                                                        ATTN:  DALLAS  PARKER
                                                           (713)  654-8111

(NAME,  ADDRESS  AND  TELEPHONE  NUMBER  OF  PERSON
AUTHORIZED  TO  RECEIVE  NOTICES  AND  COMMUNICATIONS)

                                   MARCH  13,  2000
                    (DATE  OF  EVENT  WHICH  REQUIRES  FILING
                                 OF  THIS  STATEMENT)

If  the filing person has previously filed a statement on Schedule 13G to report
the  acquisition  which  is the subject of this Schedule 13D, and is filing this
schedule  because  of    240.13d-1(e),  240.13d-1(f)  or 204.13d-1(g), check the
following  box.  [  ]

NOTE:  Schedules  filed in paper format shall include a signed original and five
copies  of  the  schedule, including all exhibits.  See   240.13d-7(b) for other
parties  to  whom  copies  are  to  be  sent.

*The  remainder  of  the cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent  amendment  containing  information  which  would  alter
disclosures  provided  in  a  prior  cover  page.

The information required on the remainder of this cover page shall not be deemed
to  be  "filed"  for the purpose of Section 18 of the Securities Exchange Act of
1934  ("Act") or otherwise subject to the liabilities of that section of the Act
but  shall  be  subject  to  all  other  provisions of the Act (however, see the
Notes).


<PAGE>
CUSIP  NO.  256095100             SCHEDULE  13D/A

(1)     Names  of Reporting Persons, I.R.S. Identification Nos. of Above Persons

          CHARLES  R.  DRUMMOND
- --------------------------------------------------------------------------------

(2)  Check  the  Appropriate Box if a Member of a Group (See Instructions)
                                                                           (a)
                                                                           (b) X
- --------------------------------------------------------------------------------
(3)  SEC  Use  Only

- --------------------------------------------------------------------------------

(4)  Source  of  Funds  (See  Instructions)                                  OO*

- --------------------------------------------------------------------------------

(5)  Check  if  Disclosure of Legal Proceedings is Required Pursuant to
                                                      Items 2(d) or  2(e)     __

- --------------------------------------------------------------------------------

(6)  Citizenship  or  Place  of  Organization                     UNITED  STATES

- --------------------------------------------------------------------------------

Number of                              (7) Sole  Voting  Power         3,157,400
                                       -----------------------------------------
Shares Benficially                     (8) Shared  Voting  Power            NONE
                                       -----------------------------------------
Owned by Each                          (9) Sole Dispositive Power      3,157,400
                                       -----------------------------------------
Reporting Person With                  (10) Shared Dispositive Power        NONE
- --------------------------------------------------------------------------------

(11)    Aggregate  Amount  Beneficially  Owned  by  Each  Reporting  Person
                                                                  3,157,400

- --------------------------------------------------------------------------------

(12)     Check  if  the  Aggregate  Amount  in  Row (11) Excludes Certain Shares
        (See Instructions)

- --------------------------------------------------------------------------------

(13)Percent  of  Class  Represented  by  Amount  in  Row  (11)               43%

- --------------------------------------------------------------------------------

(14)Type  of  Reporting  Person  (See  Instructions)IN

- --------------------------------------------------------------------------------

*  conversion  of  debt





                            AMENDMENT TO SCHEDULE 13D

                                      Page 2
<PAGE>
     This  Amendment No. 6 to Schedule 13D (this "Amendment") is filed on behalf
of  Charles  R.  Drummond with respect to his beneficial ownership of the common
stock  of  DocPlanet.com,  Inc. (formerly named docsales.com, Inc., whose former
name  was  Golden  Pharmaceuticals, Inc., whose former name was Benedict Nuclear
Pharmaceuticals,  Inc.).

     This  Amendment amends in its entirety the Schedule 13D previously filed by
Charles R. Drummond on March 12, 1991, as amended by Amendment Nos. 1 through 5.


ITEM  1.     SECURITY  AND  ISSUER.

     This  statement  relates  to shares of common stock, no par value per share
(the  "Common  Stock"),  of  DocPlanet.com, Inc. (the "Company").  The Company's
principal  executive  office  is  located  at  3000 W. Warner Avenue, Santa Ana,
California  92704-5311.

ITEM  2.     IDENTITY  AND  BACKGROUND.

     This  statement  is  being  filed  on  behalf  of Charles R. Drummond ("Mr.
Drummond").  Mr.  Drummond's  principal  occupation  or  employment is to act as
Chairman,  Chief  Executive  Officer  and  Treasurer  of  the  Company,  and his
principal  business  address  is  3000  W.  Warner Avenue, Santa Ana, California
92704-5311.

     Mr.  Drummond  has  not,  during  the  last five years, been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors).  Mr.
Drummond has not, during the last five years, been a party to a civil proceeding
of  a  judicial or administrative body of competent jurisdiction and as a result
of  such  proceeding  was  or  is  subject  to a judgment, decree or final order
enjoining  further  violations of, or prohibiting activities subject to, federal
or  state  securities  laws  or  finding  any  violation  of  such  laws.

     Mr.  Drummond  is  a  citizen  of  the  United  States.

ITEM  3.     SOURCE  AND  AMOUNT  OF  FUNDS  OR  OTHER  CONSIDERATION.

     On  March 13, 2000, Mr. Drummond converted $6,839,103 in long term debt and
accrued  interest  owed  to  him  by the Company into 2,279,701 shares of Common
Stock  of  the  Company  at  $3.00  per  share.

ITEM  4.     PURPOSE  OF  TRANSACTION.

     The  shares  of Common Stock with respect to which this filing is made were
acquired  for  investment  purposes.

     Mr. Drummond currently has no plan, proposal or intention which relates to,
or  would  result  in,  any  of  the  actions  enumerated  in any of the actions
enumerated  in  Item  4  of  the  instructions  to  Schedule  13D.

ITEM  5.     INTEREST  IN  SECURITIES  OF  THE  ISSUER.

     As  of  the  date hereof, Mr. Drummond is the beneficial owner of 3,157,400
shares  of  the  Common  Stock of the Company.  As of the date hereof, there are
7,417,092  shares  of  Common Stock outstanding, and on such basis, Mr. Drummond
beneficially  owns 43% of the Company's outstanding shares of Common Stock.  Mr.
Drummond  has  the sole power to vote, direct the vote, dispose of or direct the
disposition  of  all  shares  of  the  Company's  Common Stock that he currently
beneficially  owns.

     Except  as  otherwise  described  herein, Mr. Drummond has not effected any
transaction  in  shares  of  Common  Stock  during  the  past  60  days.


                                      Page 3
<PAGE>
ITEM  6.     CONTRACTS,  ARRANGEMENTS,  UNDERSTANDINGS  OR  RELATIONSHIPS  WITH
RESPECT  TO  THE  SECURITIES  OF  THE  ISSUER.

     In  the  past,  the  Company  has borrowed money from certain shareholders,
directors  and  officers  of the Company.  The loans are evidenced by promissory
notes  which  bear  interest  at  the  bank  prime rate plus 2%.  Certain of the
promissory  notes  were payable on demand, while certain of the promissory notes
were payable on April 1, 1998 and were past due on November 30, 1999.  By letter
dated October 29, 1999, Mr. Drummond committed not to demand payment of, or take
action  to  collect  on, the promissory notes, including those past due, owed to
him  until  August  31,  2000 or such time as the Company has the ability to pay
such  notes.

     By resolution dated December 21,1999, the Board of Directors of the Company
approved  the conversion of loans from directors and officers of the Company, in
whole  or  in  part,  into  Common  Stock  of  the  Company  at $3.00 per share.

     Pursuant  to  an  understanding  with  Charles  Wear,  in connection with a
private  purchase  of the Company's securities by Mr. Wear, Mr. Drummond and the
Company  entered  into  a  Conversion  Agreement  dated  March  13,  2000, to be
effective  as  of February 29, 2000, whereby Mr. Drummond exercised his right of
conversion  by  converting  all  of  the $6,839,103 debt, which included accrued
interest  through  February  29, 2000, owed to him by the Company into 2,279,701
shares  of  the  Company's  Common  Stock.

     Mr.  Drummond  has  no  other contracts, arrangements, or understandings or
relationships  with any person with respect to the  Common Stock of the Company.

ITEM  7.     MATERIAL  TO  BE  FILED  AS  EXHIBITS.

     No  exhibits  are  being  filed  with  this  statement.


                                      Page 4
<PAGE>
                                   SIGNATURES


     After  reasonable  inquiry  and  to  the best of my knowledge and belief, I
certify  that  the information set forth in this statement is true, complete and
correct.



Date:  March  13,  2000



By:/s/  Charles  R.  Drummond
   --------------------------


                                      Page 5
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission